LCM
NMTC icon

Legato Capital Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Legato Capital Management’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.9K Buy
10,274
+2,886
+39% +$13.9K ﹤0.01% 714
2025
Q4 		$33.6K Buy
+7,388
New +$33.6K ﹤0.01% 745

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Legato Capital Management's NMTC Position: Q1 2026 in Review

Legato Capital Management increased its NeuroOne Medical Technologies (NMTC) stake by 39% in Q1 2026, buying an estimated $13.9K and bringing the position to 10,274 shares worth $47.9K. The position accounts for ﹤0.01% of the portfolio, ranked #714.

Legato Capital Management first reported a position in NMTC in Q4 2025 and has held it in 2 quarters since. 32 funds tracked by Wall St. Rank hold NMTC as of Q1 2026.

  • Legato Capital Management held 10,274 shares of NeuroOne Medical Technologies worth $47.9K as of Q1 2026.
  • Legato Capital Management bought 2,886 NeuroOne Medical Technologies shares in Q1 2026, an estimated $13.9K.
  • NeuroOne Medical Technologies made up ﹤0.01% of Legato Capital Management's portfolio in Q1 2026, its #714 holding.
  • Legato Capital Management first reported a position in NeuroOne Medical Technologies in Q4 2025 and has held it in 2 quarters since.
  • 32 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.